$TLS
TELOS CORP Stock $tls

$tls Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000032012123000027 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$32.91M	$35.22M	$50.16M
YoY Change	-41.01%	-29.78%	-10.04%
Cost Of Revenue	$20.55M	$21.74M	$31.29M
YoY Change	-41.05%	-30.52%	-24.22%
Gross Profit	$12.36M	$13.48M	$18.87M
YoY Change	-40.95%	-28.56%	30.42%
Gross Profit Margin	37.55%	38.28%	37.62%
Selling, General & Admin	$21.83M	$26.45M	$33.61M
YoY Change	-23.7%	-21.29%	20.18%
% of Gross Profit	176.6%	196.2%	178.08%
Research & Development	$2.646M	$2.833M	$5.430M
YoY Change	-41.06%	-47.83%	33.71%
% of Gross Profit	21.41%	21.01%	28.77%
Depreciation & Amortization	$1.696M	$1.425M	$1.405M
YoY Change	12.69%	1.42%	3.31%
% of Gross Profit	13.72%	10.57%	7.45%
Operating Expenses	$24.47M	$29.29M	$39.04M
YoY Change	-26.06%	-24.98%	21.89%
Operating Profit	-$9.467M	-$12.97M	-$14.73M
YoY Change	-22.18%	-11.97%	9.19%
Interest Expense	$184.0K	$249.0K	$190.0K
YoY Change	-198.4%	31.05%	-3.06%
% of Operating Profit
Other Income/Expense, Net	$1.649M	$2.496M	$12.00K
YoY Change	1297.46%	20700.0%	-101.14%
Pretax Income	-$8.002M	-$10.72M	-$14.91M
YoY Change	-34.6%	-28.09%	1.14%
Income Tax	$22.00K	$23.00K	$71.00K
% Of Pretax Income
Net Earnings	-$8.024M	-$10.75M	-$14.98M
YoY Change	-34.71%	-28.28%	1.39%
Net Earnings / Revenue	-24.38%	-30.51%	-29.87%
Basic Earnings Per Share	-$0.12	-$0.16	-$0.22
Diluted Earnings Per Share	-$0.12	-$0.16	-$0.22
COMMON SHARES
Basic Shares Outstanding	69.39M shares	68.56M shares	67.56M shares
Diluted Shares Outstanding	69.42M shares	68.18M shares	67.56M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$103.4M	$112.5M	$120.2M
YoY Change	-15.61%	-6.46%	28.18%
Cash & Equivalents	$103.4M	$112.5M	$120.2M
Short-Term Investments
Other Short-Term Assets	$1.850M	$1.042M	$2.773M
YoY Change	-76.05%	-62.42%	256.43%
Inventory	$1.767M	$1.629M	$2.097M
Prepaid Expenses	$7.321M	$5.480M	$4.898M
Receivables	$34.29M	$34.70M	$57.73M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$148.7M	$155.3M	$187.7M
YoY Change	-19.47%	-17.27%	22.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.842M	$4.406M	$15.53M
YoY Change	-73.65%	-71.63%	-34.93%
Goodwill	$17.90M	$17.90M	$17.90M
YoY Change		0.0%	20.01%
Intangibles	$37.81M	$33.80M	$21.61M
YoY Change		56.39%
Long-Term Investments
YoY Change
Other Assets	$1.059M	$1.223M	$1.223M
YoY Change	0.67%	0.0%	23.54%
Total Long-Term Assets	$68.19M	$65.34M	$56.29M
YoY Change	18.92%	16.08%	37.04%
TOTAL ASSETS
Total Short-Term Assets	$148.7M	$155.3M	$187.7M
Total Long-Term Assets	$68.19M	$65.34M	$56.29M
Total Assets	$216.9M	$220.7M	$244.0M
YoY Change	-10.37%	-9.58%	25.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.99M	$11.68M	$35.22M
YoY Change	-24.76%	-66.83%	259.42%
Accrued Expenses	$4.521M	$6.328M	$9.219M
YoY Change	-84.52%	-31.36%	-58.1%
Deferred Revenue	$6.138M	$7.203M	$7.036M
YoY Change		2.37%	4.22%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.660M	$1.625M	$1.493M
YoY Change	8.85%	8.84%	6.64%
Total Short-Term Liabilities	$37.83M	$38.85M	$55.05M
YoY Change	-30.2%	-29.42%	7.96%
LONG-TERM LIABILITIES
Long-Term Debt	$10.41M	$10.83M	$12.46M
YoY Change	-13.76%	-13.04%	-11.02%
Other Long-Term Liabilities	$303.0K	$301.0K	$440.0K
YoY Change	-52.06%	-31.59%	-76.63%
Total Long-Term Liabilities	$303.0K	$301.0K	$440.0K
YoY Change	-97.61%	-31.59%	-76.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$37.83M	$38.85M	$55.05M
Total Long-Term Liabilities	$303.0K	$301.0K	$440.0K
Total Liabilities	$49.32M	$50.76M	$68.96M
YoY Change	-27.09%	-26.4%	1.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$259.2M	-$251.2M	-$202.0M
YoY Change	19.02%	24.36%	27.32%
Common Stock	$426.8M	$421.1M	$377.0M
YoY Change	8.88%	11.69%	32.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$167.5M	$169.9M	$175.1M
YoY Change
Total Liabilities & Shareholders Equity	$216.9M	$220.7M	$244.0M
YoY Change	-10.37%	-9.58%	25.63%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$8.024M	-$10.75M	-$14.98M
YoY Change	-34.71%	-28.28%	1.39%
Depreciation, Depletion And Amortization	$1.696M	$1.425M	$1.405M
YoY Change	12.69%	1.42%	3.31%
Cash From Operating Activities	-$4.113M	-$100.0K	$249.0K
YoY Change	-152.18%	-140.16%	-103.62%
INVESTING ACTIVITIES
Capital Expenditures	$4.445M	$223.0K	$546.0K
YoY Change	-282.62%	-59.16%	13.75%
Acquisitions
YoY Change
Other Investing Activities		-$564.0K
YoY Change
Cash From Investing Activities	-$3.881M	-$4.587M	-$3.341M
YoY Change	59.45%	37.29%	26.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.020M	-$2.156M	-$3.237M
YoY Change	-65.56%	-33.4%	17.41%
NET CHANGE
Cash From Operating Activities	-4.113M	-$100.0K	$249.0K
Cash From Investing Activities	-3.881M	-$4.587M	-$3.341M
Cash From Financing Activities	-1.020M	-$2.156M	-$3.237M
Net Change In Cash	-9.014M	-$6.843M	-$6.329M
YoY Change	-462.44%	8.12%	-48.48%
FREE CASH FLOW
Cash From Operating Activities	-$4.113M	-$100.0K	$249.0K
Capital Expenditures	$4.445M	$223.0K	$546.0K
Free Cash Flow	-$8.558M	-$323.0K	-$297.0K
YoY Change	-182.95%	8.75%	-95.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000320121
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-08443
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	TELOS CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-0880974
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	19886 Ashburn Road
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ashburn
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20147-2358
CY2023Q1	dei	City Area Code CityAreaCode	703
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	724-3800
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	TLS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	69389506	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35222000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50160000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21740000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	31289000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	13482000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	18871000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1643000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5252000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2833000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5430000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21976000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24556000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26452000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35238000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12970000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16367000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2496000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	249000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	190000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10723000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16545000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	68176000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67559000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68176000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67559000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	13000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	29000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10733000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16587000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112462000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119305000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	34702000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	40069000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1629000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2877000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5480000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4819000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1042000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	893000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	155315000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	167963000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4406000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4787000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7527000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7832000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	458000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	341000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	17922000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	17922000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33801000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	37415000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1223000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1137000	usd
CY2023Q1	us-gaap	Assets Assets	220652000	usd
CY2022Q4	us-gaap	Assets Assets	237397000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	18011000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	22551000	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	7665000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	8388000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7203000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6444000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1625000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1592000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	494000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	361000	usd
CY2023Q1	tls	Other Financing Obligations Current OtherFinancingObligationsCurrent	0	usd
CY2022Q4	tls	Other Financing Obligations Current OtherFinancingObligationsCurrent	1247000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3856000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4919000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	38854000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45502000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	10832000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	11248000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27000	usd
CY2023Q1	tls	Other Financing Obligations Noncurrent OtherFinancingObligationsNoncurrent	0	usd
CY2022Q4	tls	Other Financing Obligations Noncurrent OtherFinancingObligationsNoncurrent	7211000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	770000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	758000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	301000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	297000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	50757000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	65043000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69388256	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69388256	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67431632	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67431632	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	108000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	106000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	420980000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	412708000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-42000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-55000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-251151000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-240405000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	169895000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	172354000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	220652000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	237397000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9499000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15931000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1425000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1405000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12000	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	2000	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	12000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	89000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	95000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	17000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1427000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5279000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2014000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1248000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	850000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	927000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3563000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4489000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	674000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-364000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	495000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	758000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	655000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-477000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-15000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-100000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	249000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3800000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2795000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	223000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	546000	usd
CY2023Q1	tls	Payment Of Dft Holdback Amount PaymentOfDFTHoldbackAmount	564000	usd
CY2022Q1	tls	Payment Of Dft Holdback Amount PaymentOfDFTHoldbackAmount	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4587000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3341000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	383000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	351000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1520000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2886000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	139000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	114000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2156000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3237000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6843000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6329000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119438000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126562000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112595000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	120233000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	172354000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1584000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7916000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1942000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	169895000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	180254000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	29000	usd
CY2022Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-2886000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14280000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	175061000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	2763000	usd
CY2023Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	18520000	usd
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	13655000	usd
CY2023Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	4658000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Basis of Comparison - Revision of Previously Issued Interim Financial StatementsDuring the course of preparing the Company's consolidated financial statements for the year ended December 31, 2022, we identified that stock-based compensation expense related to performance-based restricted stock unit (“PSU”) awards with market conditions was erroneously reversed when those PSUs were forfeited during the quarter ended March 31, 2022. Although the Company has determined that the error did not have a material impact on its previously issued interim consolidated financial statements, it revised the previously reported interim financial information in conjunction with the issuance of its quarterly filings on Form 10-Q for the quarter ended March 31, 2023.
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of revenue, expenses, assets and liabilities, and disclosure of contingent assets and liabilities. The Company regularly assesses these estimates; however, actual results could differ from those estimates. We base our estimates on historical experience, currently available information, and various other assumptions that we believe are reasonable under the circumstances.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates these estimates and assumptions on an ongoing basis, including those relating to revenue recognition on cost estimation on certain contracts, allowance for credit losses, inventory obsolescence, valuation allowance for deferred tax assets, income taxes, certain assumptions related to share-based compensation, valuation of intangible assets and goodwill, restructuring expenses accruals, and contingencies. Actual results could differ from those estimates. The impact of changes in estimates is recorded in the period in which they become known.</span></div>
CY2023Q1	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	1200000	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	1673000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	2290000	usd
CY2023Q1	tls	Bill Contracts Receivable Net Of Allowance BillContractsReceivableNetOfAllowance	18297000	usd
CY2022Q4	tls	Bill Contracts Receivable Net Of Allowance BillContractsReceivableNetOfAllowance	13521000	usd
CY2023Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	4658000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	11657000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	11747000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	14891000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7203000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6444000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2500000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2500000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	77400000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.70
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.29
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	11657000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	11747000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	14891000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	223000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	134000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34702000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40069000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	2394000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	3642000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	765000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	765000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1629000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2877000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19275000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19178000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14869000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	14391000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4406000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4787000	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	600000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	600000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	17900000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	17900000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	42675000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8874000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33801000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	38750000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8455000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30295000	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	42675000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8874000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33801000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	45870000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8455000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	37415000	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	600000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11683000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12606000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6328000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9945000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	18011000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	22551000	usd
CY2023Q1	tls	Other Accrued Expenses Current OtherAccruedExpensesCurrent	874000	usd
CY2022Q4	tls	Other Accrued Expenses Current OtherAccruedExpensesCurrent	1530000	usd
CY2023Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	2290000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	2763000	usd
CY2023Q1	tls	Other Current Liabilities Other OtherCurrentLiabilitiesOther	692000	usd
CY2022Q4	tls	Other Current Liabilities Other OtherCurrentLiabilitiesOther	626000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3856000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4919000	usd
CY2022Q4	tls	Debt Instrument Covenant Senior Leverage Ratio Maximum DebtInstrumentCovenantSeniorLeverageRatioMaximum	3
CY2023Q1	us-gaap	Other Income OtherIncome	1400000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2135135	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.67
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	5400000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9499000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15931000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3906867	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.53
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	205540	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.87
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1535288	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	26.71
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	441984	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	14.66
CY2022Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	38700000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35222000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50160000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	219000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	410000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q1	tls	Incremental Common Shares Excluded From The Dilutive Effect IncrementalCommonSharesExcludedFromTheDilutiveEffect	265608	shares
CY2022Q1	tls	Incremental Common Shares Excluded From The Dilutive Effect IncrementalCommonSharesExcludedFromTheDilutiveEffect	439786	shares
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Gross Profit GrossProfit	13482000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	18871000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26452000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35238000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12970000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16367000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2496000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	249000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	190000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10723000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16545000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10746000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112462000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119305000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	133000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	133000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112595000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119438000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	179000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	117000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	147000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	273000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023Q1	tls	Withholding Tax On Net Share Settlement Under Other Current Liabilities WithholdingTaxOnNetShareSettlementUnderOtherCurrentLiabilities	65000	usd
CY2022Q1	tls	Withholding Tax On Net Share Settlement Under Other Current Liabilities WithholdingTaxOnNetShareSettlementUnderOtherCurrentLiabilities	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1942000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	tls	Intangible Assets Transferred To Extinguish Other Financing Obligations IntangibleAssetsTransferredToExtinguishOtherFinancingObligations	7089000	usd
CY2022Q1	tls	Intangible Assets Transferred To Extinguish Other Financing Obligations IntangibleAssetsTransferredToExtinguishOtherFinancingObligations	0	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24556000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35238000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16367000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16545000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16587000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-16616000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000320121-23-000027-index-headers.html	Edgar Link	pending
0000320121-23-000027-index.html	Edgar Link	pending
0000320121-23-000027.txt	Edgar Link	pending
0000320121-23-000027-xbrl.zip	Edgar Link	pending
a1stamendmenttothecreditag.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tls-20230331.htm	Edgar Link	pending
tls-20230331.xsd	Edgar Link	pending
tls-20230331xexhibit311q1.htm	Edgar Link	pending
tls-20230331xexhibit312q1.htm	Edgar Link	pending
tls-20230331xexhibit32q1.htm	Edgar Link	pending
tls-20230331_g1.jpg	Edgar Link	pending
tls-20230331_cal.xml	Edgar Link	unprocessable
tls-20230331_def.xml	Edgar Link	unprocessable
tls-20230331_pre.xml	Edgar Link	unprocessable
tls-20230331_lab.xml	Edgar Link	unprocessable
tls-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLS
TELOS CORP Stock $tls

2023 Q2 Form 10-Q Financial Statement

#000032012123000027 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLS TELOS CORP Stock $tls

2023 Q2 Form 10-Q Financial Statement

#000032012123000027 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLS
TELOS CORP Stock $tls